MedPath

The Effects of Omega 3 and Vitamin E Supplementation on the Serum Antioxidant Enzymes and Gene Expressions of PGC-1a, h TERT, FOXOs and SIRTs in CAD Patients

Phase 4
Conditions
Coronary Artery Disease
Registration Number
NCT02011906
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

The aim of this study is to determine the effects of omega 3 supplementation and its concurrent supplementation with vitamin E on the serum levels of antioxidant enzymes and the expressions of the PGC-1a, h TERT, FOXO1, FOXO3a , SIRT1,SIRT3, SIRT6 genes in PBMC cells in the patients with coronary artery disease

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
20
Inclusion Criteria

literate, willingness to participation, CAD patients 45- 65 years old, body mass index< 30, avoidance of dietary supplements, vitamins and herbal products at least 3 months before and throughout the intervention, willing to maintain body weight during the study

Exclusion Criteria
  • people who have used vitamin E or omega 3 supplements in last 3 months, having chronic renal disease ,cancer, Hepatobilliary diseases, hematological disorders, hypo- or hyperthyroidism, diabetes, treatment with PPAR-gamma agonists or Thiazolidinediones, Smokers

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
serum HDL cholesterolchange from baseline at 2 months
serum triglycerides levelchange from baseline at 2 months
serum LDL cholesterolchange from baseline at 2 months
serum total cholesterolchange from baseline at 2 months
serum insulinchange from baseline at 2 months
serum Hs-CRPchange from baseline at 2 months
serum gluthatione peroxidasechange from baseline at 2 months
serum catalasechange from baseline at 2 months
serum superoxide dismutasechange from baseline at 2 months
serum total antioxidant capacitychange from baseline at 2 months
Secondary Outcome Measures
NameTimeMethod
gene expression of SIRT1change from baseline at 2 months
gene expression of SIRT3change from baseline at 2 months
gene expression of SIRT6change from baseline at 2 months
gene expression of PGC-1achange from baseline at 2 months
gene expression of FOXO3achange from baseline at 2 months
gene expression of FOXO1change from baseline at 2 months
gene expression of h TERTchange from baseline at 2 months

Trial Locations

Locations (1)

Tehran University of Medical Sciences

🇮🇷

Tehran, Iran, Islamic Republic of

Tehran University of Medical Sciences
🇮🇷Tehran, Iran, Islamic Republic of

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.